Here's What Boosted Tempus AI (TEM) in Q1
In its first quarter 2025 investor letter, Frontier Small Cap Growth Fund highlighted stocks such as Tempus AI, Inc. (NASDAQ:TEM). Tempus AI, Inc. (NASDAQ:TEM) is a healthcare technology company. The one-month return of Tempus AI, Inc. (NASDAQ:TEM) was -1.77%, and its shares gained 97.44% of their value over the last 52 weeks. On July 3, 2025, Tempus AI, Inc. (NASDAQ:TEM) stock closed at $60.99 per share, with a market capitalization of $10.558 billion.
Frontier Small Cap Growth Fund stated the following regarding Tempus AI, Inc. (NASDAQ:TEM) in its first quarter 2025 investor letter:
"Our best contributing stock was Tempus AI, gaining 43% on the back of robust growth and the end of its initial public offering (IPO) lockup period. Tempus AI, Inc. (NASDAQ:TEM) is a health care company that combines its next generation diagnostics platform across multiple diseases with its leading data and analytics capabilities. Tempus is rooted in clinical care delivery as one of the largest sequencers of cancer patients and patients with other diseases. The company is building an intelligent diagnostics platform through the application of its artificial intelligence (AI) capabilities to allow physicians to deliver more personalized and data-driven therapies to patients and to help researchers develop more precise therapies. The Tempus platform collects numerous data types, and unlike peers, the data comes not only from its own labs but also from a variety of sources including more than 2,000 health care institutions and more than half of the practicing U.S. oncologists. Today, Tempus has a multimodal, de-identified database that is much larger than any other company or institution. This database creates a substantial economic moat and additional revenue stream for the company when it licenses the data to pharma companies to aid in therapy development. The company's recent rapid growth has been driven both by increased testing volumes, higher realized average selling prices, as more payors are covering their tests, and improved coverage and price through Medicare. While not yet profitable, Tempus guided slightly positive Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for 2025, a meaningful improvement compared to 2024 and prior periods."
A doctor administering a diagnostic test kit for the detection of gastrointestinal diseases.
Tempus AI, Inc. (NASDAQ:TEM) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held Tempus AI, Inc. (NASDAQ:TEM) at the end of the first quarter, compared to 17 in the previous quarter. In the first quarter of 2025, Tempus AI, Inc.'s (NASDAQ:TEM) revenue increased 75.4% year-over-year to $255.7 million. While we acknowledge the potential of Tempus AI, Inc. (NASDAQ:TEM) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the undervalued AI stock set for massive gains.
In another article, we covered Tempus AI, Inc. (NASDAQ:TEM) and shared the list of top healthcare AI stocks to buy according to hedge funds. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. While we acknowledge the potential of TEM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
Oil Dips as Traders Take Stock of US Tariffs and OPEC+ Shift
(Bloomberg) -- Oil slipped for the third time in four days as investors focused on the fallout from a wave of US trade levies and a decision by OPEC+ to restore more of the group's idled capacity. Are Tourists Ruining Europe? How Locals Are Pushing Back Trump's Gilded Design Style May Be Gaudy. But Don't Call it 'Rococo.' Denver City Hall Takes a Page From NASA In California, Pro-Housing 'Abundance' Fans Rewrite an Environmental Landmark Can Mamdani Bring Free Buses to New York City? Brent dipped toward $69 a barrel and West Texas Intermediate was below $68. President Donald Trump threatened new tariff rates on trading partners, while suggesting that he was still open to negotiations. The duties on countries including Japan and South Korea won't take effect until at least Aug. 1. 'Traders are watching Trump's new tariff threats and global growth risks, which could soften demand,' said Haris Khurshid, chief investment officer at Karobaar Capital LP. 'Looking ahead, we should be paying attention to any new OPEC+ signals about extending or adjusting supply cuts.' Oil closed higher on Monday after sliding at the open following a decision by OPEC+ to boost output more than expected in August. The group cited summer demand as one reason for their optimism that the barrels could be absorbed, and Saudi Arabia raised the price of its main crude grade to Asia. The oil market has been volatile in recent weeks after the war between Israel and Iran, with a fragile truce now in place, but tensions in the Middle East are starting to rise again following fresh attacks in the Red Sea. A second vessel was targeted near Yemen on Monday, hours after Iranian-backed Houthis claimed responsibility for an earlier attack on a ship in the same area. 'These attacks raise supply-chain costs and insurance premiums for oil cargoes,' said Khurshid. 'But unless there's a major supply disruption, the impact stays mostly at the margins.' Elsewhere, there are signs of tightness showing in the diesel market, as traders grapple with a summer supply squeeze. US stockpiles are at the lowest seasonally since 1996, while Europe benchmark futures signal a tighter market than during the height of the recent Israel-Iran conflict. SNAP Cuts in Big Tax Bill Will Hit a Lot of Trump Voters Too 'Telecom Is the New Tequila': Behind the Celebrity Wireless Boom For Brazil's Criminals, Coffee Beans Are the Target Sperm Freezing Is a New Hot Market for Startups Pistachios Are Everywhere Right Now, Not Just in Dubai Chocolate ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26 minutes ago
- Yahoo
IvyPanda Launches AI-Powered Case Study Solver to Support Academic & Professional Analysis
Sheridan, Wyoming--(Newsfile Corp. - July 8, 2025) - IvyPanda, a company specializing in innovative tools and other educational resources, has introduced the AI Case Study Solver - an AI-driven solution that revolutionizes how case studies are approached. With this speedy tool, it's possible to do complex analysis on any topic quickly and receive clear, structured insights in mere seconds. IvyPanda - AI Case Study Solver "We've created the Case Study Analyzer to bridge the gap between complexity and clarity," says Hanna Sheremet, CEO of IvyPanda. "By automating the analysis process, we help students, educators, and professionals focus on deeper aspects of various cases and their actionable solutions." The IvyPanda Case Study Solver is ideal for anyone working with detailed case studies, whether in academia, research, medicine, business, or other fields. It's a universal tool for tackling challenging assignments, boosting the work process, and making accurate decisions. Who can benefit from the AI case study analyzer? Students can simplify academic assignments and instantly build a solid foundation for presentations or papers. Professionals can quickly break down business cases, healthcare reports, or legal scenarios for actionable insights. Educators can develop teaching materials or case study solutions more efficiently. Researchers can save time while focusing on deeper analysis and hypothesis testing. What makes the instrument special One of the Case Study Analyzer's standout features is its accessibility. IvyPanda has ensured that the tool is entirely free to use, with no registration or hidden costs. It's also unlimited, giving users the freedom to analyze multiple case studies without barriers. Other key features of the new tool are: AI-powered precision Customization opportunities Structured outputs User-friendly design Adaptability Using the Case Study Analyzer is simple: Paste up to 2,000 words of a case study into the tool. Add specific questions for targeted results (optional). Let the AI deliver a detailed analysis. In just a few moments, users receive structured summaries with identified challenges and actionable recommendations. The tool's advanced algorithms not only allow it to produce results quickly but also ensure clear and easy-to-understand output. All this makes the tool a perfect solution for users of all experience levels. About IvyPanda Since 2015, IvyPanda has been a trusted brand in academic support internationally. Headquartered in the US and Estonia, the company offers students and professionals a comprehensive suite of resources, from writing tools to study guides. IvyPanda's mission is to make learning smarter, more engaging, and more accessible for users worldwide. To learn more about the company and to try the Case Study Analyzer, visit the official website of IvyPanda. Hanna SheremetIvyPanda Study Hubwelcome@ To view the source version of this press release, please visit
TechCrunch
36 minutes ago
- TechCrunch
OpenAI tightens the screws on security to keep away prying eyes
In Brief OpenAI has reportedly overhauled its security operations to protect against corporate espionage. According to the Financial Times, the company accelerated an existing security clampdown after Chinese startup DeepSeek released a competing model in January, with OpenAI alleging that DeepSeek improperly copied its models using 'distillation' techniques. The beefed-up security includes 'information tenting' policies that limit staff access to sensitive algorithms and new products. For example, during development of OpenAI's o1 model, only verified team members who had been read into the project could discuss it in shared office spaces, according to the FT. And there's more. OpenAI now isolates proprietary technology in offline computer systems, implements biometric access controls for office areas (it scans employees' fingerprints), and maintains a 'deny-by-default' internet policy requiring explicit approval for external connections, per the report, which further adds that the company has increased physical security at data centers and expanded its cybersecurity personnel. The changes are said to reflect broader concerns about foreign adversaries attempting to steal OpenAI's intellectual property, though given the ongoing poaching wars amid American AI companies and increasingly frequent leaks of CEO Sam Altman's comments, OpenAI may be attempting to address internal security issues, too. We've reached out to OpenAI for comment.
